Chromoanasynthesis is a common mechanism that leads to ERBB2 amplifications in a cohort of early stage HER2+ breast cancer samples

HER2 positive (HER2+) breast cancers involve chromosomal structural alterations that act as oncogenic driver events. Chromoanasynthesis involving chromosome 17 can lead to ERBB2 amplifications in HER2+ breast cancer.